Humana Inc. (HUM) News
Filter HUM News Items
HUM News Results
|Loading, please wait...|
HUM News Highlights
- HUM's 30 day story count now stands at 20.
- Over the past 23 days, the trend for HUM's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about HUM are CI, DRUG and BASE.
Latest HUM News From Around the Web
Below are the latest news stories about HUMANA INC that investors may wish to consider to help them evaluate HUM as an investment opportunity.
2 Great Value Stocks to Buy in April and Hold for Years
After the bullish first quarter, we dig into two highly-ranked Zacks stocks--Humana (HUM) and O-I Glass, Inc. (OI)--that offer investors great value, alongside the ability to thrive in all types of economic conditions.
Humana Healthy Horizons Commits $488,000 to Improve Health of Texans
AUSTIN, Texas, March 30, 2023--Humana Healthy Horizons commits $488,000 to improve health of Texans through investments in community organizations.
Humana Inc. to Release First Quarter 2023 Results on April 26, 2023
LOUISVILLE, Ky., March 29, 2023--Humana Inc. (NYSE: HUM) will release its financial results for the first quarter 2023 (1Q23) on Wednesday, April 26, 2023, at 6:30 a.m. Eastern time. The company will host a conference call at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2023.
Humana and Thomas Jefferson University Announce Collaboration to Advance Health Equity and Community Health in Greater Philadelphia
LOUISVILLE, Ky., March 29, 2023--Humana and Thomas Jefferson University announce collaboration to advance health equity and community health in greater Philadelphia
Here is What to Know Beyond Why Humana Inc. (HUM) is a Trending Stock
Humana (HUM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Does Big Pharmacy Managers Fix Prices? Ohio Attorney General Lawsuit Alleges Cigna, Humana Engaged In Price Fixing For Medicines
A lawsuit filed by the Ohio attorney general alleges that Cigna Corp (NYSE: CI), Humana Inc (NYSE: HUM), and Prime Therapeutics LLC shared pricing and other information to gain leverage during negotiations for rebates. The lawsuit comes as some policymakers explore the healthcare companies' role in high-cost drugs, Wall Street Journal reported. The Federal Trade Commission, House Republicans, and several states have launched investigations into pharmacy-benefit managers (PBMs). Governments, empl
Drug Middlemen Accused of Price Fixing by Ohio Attorney General
The state’s lawsuit alleged certain pharmacy-benefit managers shared drug pricing and other information to gain leverage during rebate negotiations with pharmaceutical companies.
UPDATE 3-Cigna's PBM, two others sued in Ohio over drug price fixing
accusing Cigna Group, Humana Inc and others of colluding to drive up prescription drug prices by charging exorbitant fees for pharmacy benefit management services. regulators of pharmacy benefit managers (PBMs) like Cigna's Express Scripts unit, which is named as a defendant.
Humana Stock Is a Bet on Healthcare for Seniors
The insurer is looking beyond Medicare Advantage and beefing up its senior-focused CenterWell business. Its stock could rise 27%.
David A. Jones Elected Chairman of the Humana Foundation Board of Directors
LOUISVILLE, Ky., March 22, 2023--The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 41 years, today announced that David A. Jones Jr. has been elected to serve as Chairman of the Board of Directors, effective as of April 1, 2023.